# Recent advances in the detection technologies for balanced chromosomal rearrangements

**Authors:** Meng Gao, Jun Ren, Shanling Liu

PMC · DOI: 10.3389/fgene.2026.1763846 · Frontiers in Genetics · 2026-02-13

## TL;DR

This paper reviews recent technologies for detecting balanced chromosomal rearrangements, which are challenging to identify due to their lack of genetic material gain or loss.

## Contribution

The paper provides a comprehensive review of emerging technologies for detecting balanced chromosomal rearrangements.

## Key findings

- Traditional methods like karyotyping and FISH are ineffective for detecting submicroscopic BCRs.
- Long-read sequencing and optical genome mapping show promise in identifying BCR breakpoints.
- Improved short-read sequencing methods, such as mate-pair sequencing, can detect balanced rearrangements.

## Abstract

Balanced chromosomal rearrangements (BCRs) refer to a type of chromosomal structural variations without chromosomal gains or losses. BCR carriers may experience fertility issues, including a higher risk of infertility, recurrent miscarriages, or having offspring with chromosomal abnormalities. Since there are no apparent gains or losses of genetic materials in BCR carriers, their detection has long been a focal and challenging issue in the field of chromosomal structural variation analysis. Karyotyping cannot detect submicroscopic rearrangements because of restricted resolution and the application of fluorescence in situ hybridization (FISH) is limited by the necessity of a known loci. Chromosomal microarray analysis and standard short-read sequencing, widely used in clinical practice, cannot detect BCRs. In summary, the clinical detection techniques are unable to accurately identify the breakpoints of BCRs. The improved short-read sequencing such as mate-pair sequencing has been found to detect balanced rearrangements. Emerging advanced technologies such as long-read sequencing, and optical genome mapping, have already shown their potential in detecting BCRs. This review primarily elucidates the principles, applicability, advantages, and limitations of the detection techniques for BCRs, aiming to assist in the early identification and appropriate advice of patients with BCRs in genetic counseling.

## Full-text entities

- **Genes:** APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080] {aka ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR}, BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613] {aka ALL, BCR1, CML, D22S11, D22S662, PHL}
- **Diseases:** azoospermia (MESH:D053713), colorectal cancer (MESH:D015179), infertility (MESH:D007246), recurrent miscarriage (MESH:D000026), OGM (MESH:D042822), miscarriage (MESH:D000022), LRS (MESH:D004410), BCRs (MESH:D002869), Cancer (MESH:D009369), in vitro fertilization (IVF) failure (MESH:D051437), neurodevelopmental or other neuropsychiatric disorders (MESH:D001523), PGT-SR (MESH:D013736), male infertility (MESH:D007248), genetic disorders (MESH:D030342), MPS (MESH:C537238)
- **Chemicals:** ONT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** T2T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945333/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12945333/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945333/full.md

---
Source: https://tomesphere.com/paper/PMC12945333